全文获取类型
收费全文 | 5535篇 |
免费 | 489篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 201篇 |
妇产科学 | 104篇 |
基础医学 | 660篇 |
口腔科学 | 220篇 |
临床医学 | 676篇 |
内科学 | 1131篇 |
皮肤病学 | 67篇 |
神经病学 | 553篇 |
特种医学 | 281篇 |
外科学 | 467篇 |
综合类 | 148篇 |
一般理论 | 3篇 |
预防医学 | 649篇 |
眼科学 | 69篇 |
药学 | 476篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 338篇 |
出版年
2022年 | 38篇 |
2021年 | 75篇 |
2020年 | 48篇 |
2019年 | 73篇 |
2018年 | 95篇 |
2017年 | 75篇 |
2016年 | 86篇 |
2015年 | 92篇 |
2014年 | 131篇 |
2013年 | 184篇 |
2012年 | 264篇 |
2011年 | 251篇 |
2010年 | 168篇 |
2009年 | 204篇 |
2008年 | 250篇 |
2007年 | 243篇 |
2006年 | 188篇 |
2005年 | 219篇 |
2004年 | 178篇 |
2003年 | 179篇 |
2002年 | 210篇 |
2001年 | 163篇 |
2000年 | 177篇 |
1999年 | 149篇 |
1998年 | 120篇 |
1997年 | 121篇 |
1996年 | 98篇 |
1995年 | 88篇 |
1994年 | 67篇 |
1993年 | 77篇 |
1992年 | 120篇 |
1991年 | 100篇 |
1990年 | 115篇 |
1989年 | 105篇 |
1988年 | 108篇 |
1987年 | 101篇 |
1986年 | 108篇 |
1985年 | 93篇 |
1984年 | 70篇 |
1983年 | 66篇 |
1982年 | 54篇 |
1981年 | 45篇 |
1980年 | 40篇 |
1979年 | 55篇 |
1978年 | 51篇 |
1977年 | 43篇 |
1974年 | 41篇 |
1973年 | 36篇 |
1970年 | 42篇 |
1968年 | 42篇 |
排序方式: 共有6072条查询结果,搜索用时 15 毫秒
1.
Christian Holm Hansen Shelley Lees Saidi Kapiga Janet Seeley Tony Barnett 《Global public health》2020,15(3):402-413
ABSTRACTMeasuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised. 相似文献
2.
The midwifery art has emphasised the uniqueness of human beings throughout its Nordic history. The educated Nordic midwife has in the last decade celebrated several hundred years of memories. This article studies how the key ideas of the midwifery art and patterns of ideas become evident in the zeitgeist from the beginning of the 19th century to the millennium in the Nordic countries. The legacy and pattern of ideas of the art of midwifery are interpreted in relation to the texts of the selected historical sources and based on Ricoeur's phenomenological-hermeneutic approach to the text and further to the dedication of understanding and interpretation. The historical sources refer to unprinted primary sources from historical archives and printed secondary and tertiary sources. The patterns of ideas include a tripartite whole: the true cultivation of the head, the philosophy and aesthetics of the hand, the strength of the heart and the drive of calling. These ideas open for unique visions and attest to the evident in modern midwives. Today's midwives have academic training with examinations, and the education is based on scientific evidence. The midwife profession is authorised by the state and supervised by the authorities. 相似文献
3.
颈动脉内膜切除术的恰当应用 总被引:2,自引:0,他引:2
在颈动脉内膜切除术(CEA)首创的头30年里,一直没有明确的标准来确定哪些颈内动脉疾病患者适合这一手术.最近,从7项临床随机试验中得出了哪些有症状与无症状患者适合行CEA的结论.对于颈内动脉狭窄70%以上的患者,卒中的危险性最大,手术的益处也最大.在这些研究中,CEA对以下患者最有益半球短暂性脑缺血发作、颅内外联合病灶和无侧支循环且除此之外身体状况良好的老年患者.下列患者虽然能从手术中获益,但围手术期卒中和死亡的危险性较高广泛白质疏松、对侧颈内动脉闭塞和腔内有血栓者.狭窄50%~69%的患者较少获益,包括女性和仅有一过性单眼盲在内的一些患者行CEA甚至可能有害.腔隙性卒中和一侧颈内动脉接近闭塞的患者有手术指征,但益处不大;狭窄<50%的患者不能从手术中获益.在最大的一项无症状患者随机试验中,围手术期卒中和死亡的危险性非常小(1.5%),但要在2年内防止1例卒中发生需要相当多的病例(83例)接受CEA治疗.以后的文献报道围手术期危险性较高(2.8%~5.6%).近一半无症状患者的卒中是心源性栓塞和小血管疾病所致.这些局限性抵消了任何潜在的益处.其他试验正在进行,并可能确认哪些无症状患者亚组可从手术中获益.同时,大多数无症状患者内科治疗效果也较好. 相似文献
4.
5.
6.
R J Gatchel T G Mayer P Capra J Barnett P Diamond 《Archives of physical medicine and rehabilitation》1986,67(12):878-882
The present study evaluated the use of psychologic measures, in particular, the relatively new Million Behavioral Health Inventory (MBHI), in predicting change in physical function of chronic low back pain patients undergoing a functional restoration program. The first 134 consecutive patients completing this program were assessed. Results demonstrated that various clinical scales of the MBHI were predictive of improvement in physical function. In addition, various scales enabled discrimination between patients who completed the program and those who prematurely dropped out. Although this inventory shows promise in helping to predict response to treatment, no single psychologic test can reliably be used as the sole predictor in clinical cases. 相似文献
7.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
8.
9.
This article is designed to help dentists make better decisions regarding capitation programs. It focuses on approaches to costs that can be useful. An example is given that illustrates how these cost concepts might be used to analyze a capitation proposal. 相似文献
10.